top of page

TB Research Group

at the University of Pittsburgh

Center for Vaccine Research

We are a group of 6 labs that study the immunology of tuberculosis and associated infections. We collaborate with each other, other labs at the University of Pittsburgh, and experts across the country and around the world to answer key questions about the world's leading infectious killer. Our work focuses on immune mechanisms, vaccines, and medical imaging.

Why TB?

Tuberculosis (TB) remains the most deadly infectious disease worldwide and kills ~2 million people per year. It is estimated that 1/3 of the world's population is latently or sub-clinically infected by M. tuberculosis, and 10% of infected persons will develop active disease. This silent pandemic disproportionately affects LMIC as a result of ineffective vaccines and expensive, lengthy treatment regimens. Co-infection with HIV worsens outcomes, and TB is the leading cause of death among people living with HIV.

 

Our research encompasses translational studies on drugs, vaccines, and immune modulation of these diseases.

Our Expertise:

Disease progression

We track infection dynamics over time, offering unique insight into the processes behind Mtb infection

HIV co-infection

HIV and TB synergistically devastate the immune system. We use SIV to study how these two infections interact.

Vaccination platforms

We are able to use various disease models to study key mechanisms of vaccine-induced protection.

lung3.png

PET/CT imaging

Serial PET/CT imaging throughout infections gives spatial and temporal data about structural and inflammatory processes.

Drug regimens

With antimicrobial resistance on the rise, there is an urgent need to study new compounds and combinations, and understand their impact on infection dynamics

Join Our Group!

We are actively recruiting postdocs, graduate students, and staff!

Prospective graduate students should ask about the Program in Microbiology and Immunology (PMI).

Staff needs include: laboratory technicians, medical imaging analysis, data science and management.

Reach out to:

JoAnne Flynn - joanne@pitt.edu

Chuck Scanga - scangaca@pitt.edu

Ling Lin - philana.lin@chp.edu

Josh Mattila - jmattila@pitt.edu

Patty Grace - patricia.grace@pitt.edu

Protection against reinfection with Mycobacterium tuberculosis extends across heterologous Mtb lineages

Mechanisms of Protection, NHP model of Mtb Infection, TB Disease

Related to:

Andrew W Simonson, Michael C Chao, Luke E Hood, Rachel A Donlan, Forrest Hopkins, Michael R Chase, Andrew J Vickers, Alanna Callendrello, Edwin Klein, HJacob Borish, Marshall Malin, Pauline Maiello, Charles A Scanga, Philana Ling Lin, Sarah M Fortune, JoAnne L Flynn

Published on

November 2, 2025

Mucosal Immunology

CD4+ T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection

Mechanisms of Protection, T cell Dynamics in TB

Related to:

Joshua D Bromley*, Sharie Keanne C Ganchua*, Sarah K Nyquist, Pauline Maiello, Michael Chao, H Jacob Borish, Mark Rodgers, Jaime Tomko, Kara Kracinovsky, Douaa Mugahid, Son Nguyen, Qianchang Dennis Wang, Jacob M Rosenberg, Edwin C Klein, Hannah P Gideon, Roisin Floyd-O’Sullivan, Bonnie Berger, Charles A Scanga, Philana Ling Lin, Sarah M Fortune, Alex K Shalek, JoAnne L Flynn

Published on

October 8, 2024

Immunity

A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity

Mechanisms of Protection, TB Vaccines

Related to:

Alexander A Smith*, Hongwei Su*, Joshua Wallach*, Yao Liu, Pauline Maiello, H Jacob Borish, Caylin Winchell, Andrew W Simonson, Philana Ling Lin, Mark Rodgers, Daniel Fillmore, Jennifer Sakal, Kan Lin, Valerie Vinette, Dirk Schnappinger, Sabine Ehrt, JoAnne L Flynn

Published on

January 10, 2025

Nature Microbiology

Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes

Mechanisms of Protection, T cell Dynamics in TB, TB Vaccines

Related to:

Andrew W Simonson*, Joseph J Zeppa*, Allison N Bucsan*, Michael C Chao, Supriya Pokkali, Forrest Hopkins, Michael R Chase, Andrew J Vickers, Matthew S Sutton, Caylin G Winchell, Amy J Myers, Cassaundra L Ameel, Ryan J Kelly, Ben Krouse, Luke E Hood, Jiaxiang Li, Chelsea C Lehman, Megha Kamath, Jaime Tomko, Mark A Rodgers, Rachel Donlan, Harris Chishti, H Jacob Borish, Edwin Klein, Charles A Scanga, Sarah M Fortune, Philana Ling Lin, Pauline Maiello, Mario Roederer, Patricia A Darrah, Robert A Seder, JoAnne L Flynn

Published on

February 6, 2025

Journal of Experimental Medicine

Transiently boosting Vγ9+ Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance

Mechanisms of Protection, SIV Co-infection, T cell Dynamics in TB

Related to:

Erica C Larson, Amy L Ellis, Mark A Rodgers, Abigail K Gubernat, Janelle L Gleim, Ryan V Moriarty, Alexis J Balgeman, Yonne T de Menezes, Cassaundra L Ameel, Daniel J Fillmore, Skyler M Pergalske, Jennifer A Juno, Pauline Maiello, Harris B Chishti, Philana Ling Lin, Dale I Godfrey, Stephen J Kent, Daniel G Pellicci, Lishomwa C Ndhlovu, Shelby L O'Connor, Charles A Scanga

Published on

December 10, 2024

Infection and Immunity

CD8+ lymphocytes are critical for early control of tuberculosis in macaques

T cell Dynamics in TB

Related to:

Caylin G Winchell, Sarah K Nyquist, Michael C Chao, Pauline Maiello, Amy J Myers, Forrest Hopkins, Michael Chase, Hannah P Gideon, Kush V Patel, Joshua D Bromley, Andrew W Simonson, Roisin Floyd-O’Sullivan, Marc Wadsworth, Jacob M Rosenberg, Rockib Uddin, Travis Hughes, Ryan J Kelly, Josephine Griffo, Jaime Tomko, Edwin Klein, Bonnie Berger, Charles A Scanga, Joshua Mattila, Sarah M Fortune, Alex K Shalek, Philana Ling Lin, JoAnne L Flynn

Published on

October 16, 2023

Journal of Experimental Medicine

Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis

SIV Co-infection, TB Vaccines

Related to:

Erica C Larson, Amy L Ellis-Connell, Mark A Rodgers, Abigail K Gubernat, Janelle L Gleim, Ryan V Moriarty, Alexis J Balgeman, Cassaundra L Ameel, Solomon Jauro, Jaime A Tomko, Kara B Kracinovsky, Pauline Maiello, H Jake Borish, Alexander G White, Edwin Klein, Allison N Bucsan, Patricia A Darrah, Robert A Seder, Mario Roederer, Philana Ling Lin, JoAnne L Flynn, Shelby L O’Connor, Charles A Scanga

Published on

October 9, 2023

Nature Microbiology

Antibiotic treatment modestly reduces protection against Mycobacterium tuberculosis reinfection in macaques

Drug Treatment, Mechanisms of Protection

Related to:

Sharie Keanne Ganchua, Pauline Maiello, Michael Chao, Forrest Hopkins, Douaa Mugahid, Philana Ling Lin, Sarah M Fortune, JoAnne L Flynn

Published on

April 9, 2024

Infection and Immunity

Mycobacterium tuberculosis-Specific CD4 T Cells Expressing Transcription Factors T-Bet or RORγT Associate with Bacterial Control in Granulomas

Mechanisms of Protection, T cell Dynamics in TB

Related to:

Nicole L Grant, Kristen Kelly, Pauline Maiello, Helena Abbott, Shelby O'Connor, Philana Ling Lin, Charles A Scanga, JoAnne L Flynn

Published on

April 11, 2023

mBio

Characterizing the Spectrum of Latent Mycobacterium tuberculosis in the Cynomolgus Macaque Model: Clinical, Immunologic, and Imaging Features of Evolution

NHP model of Mtb Infection

Related to:

Jessica Marie Medrano, Pauline Maiello, Tara Rutledge, Jaime Tomko, Mark A Rodgers, Daniel Fillmore, L James Frye, Christopher Janssen, Edwin Klein, JoAnne L Flynn, Philana Ling Lin

Published on

February 14, 2023

Journal of Infectious Diseases

Immune cell interactions in tuberculosis

Mechanisms of Protection

Related to:

JoAnne L Flynn, John Chan

Published on

December 8, 2022

Cell

Recent Publications

bottom of page